Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowPlacement
Just nowQ3 FY26 Activities Report and Appendix 4C
Just nowFY26 Q1 Quarterly Activities Report and Appendix 4C
Just nowMarch 2026 Quarterly Activities & Cashflow Report
Just nowMarch 2026 Quarterly Activities Report and Appendix 4C
Envoy Medical Inc. logo

Envoy Medical Inc.

About

Envoy Medical Inc. (NASDAQ:COCH) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 22 2026
Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
Apr 16 2026
Envoy Medical Appoints Chas McKhann to Board of Directors
Apr 1 2026
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant
Mar 23 2026
Envoy Medical Reports Full Year 2025 Financial Results
Mar 11 2026
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant

Financials

Revenue
$241 K
Market Cap
$54.2 M
EPS
-1.23

Community Chat

Ask AI

6ix6ix